John Nolte
Family Medicine · Anchorage, AKNPI 1689678211
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $514 and has fallen 90.8% since, to $47 in 2025.
Across 59 payments — averaging $28.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$392
- Amgen$296
- AbbVie$239
- AstraZeneca$201
- Bristol Myers Squibb$141
- Pfizer$74
- plus $356 from 13 others
Across 5 payments — averaging $27,048 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$135K
What the payments were for
- Food & beverage$1,699100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $392 |
| Amgen | 8 | $296 |
| AbbVie(2 entities) | 8 | $239 |
| AstraZeneca | 8 | $201 |
| Bristol Myers Squibb | 2 | $141 |
| Pfizer | 4 | $74 |
| GSK | 4 | $69 |
| Lilly USA, LLC | 3 | $50 |
| Dexcom, Inc. | 1 | $31 |
| Johnson & Johnson | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $20 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,699 in reported general payments places this provider in the 85th percentile of 334 family medicine providers in Alaska.
Other family medicine in Anchorage
- Mary FolandAnchorage$15K
- Ilona FarrAnchorage$14K
- Eric MiknichAnchorage$13K
- Allison KelliherAnchorage$6K
- Bruce KiesslingAnchorage$5K
- Kathryn RyanAnchorage$5K
- Bruck CliftAnchorage$5K
- Ulyana StiassnyAnchorage$4K
- Pebbles ShanleyAnchorage$4K
- Kenneth MollAnchorage$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.